Most health-related issues have a global nature and require a global solution. The European Union (EU) alone will not crack the challenge of implementing personalised medicine and better healthcare for all. The ability to attract international stakeholders (e.g. funding agencies) and their resources into EU–led collaborations will help the EU to combine best skills and outcomes, and deliver tangible results to patients.
International cooperation is therefore not an option but a fundamental and inherent component of the health research programme.
Multilateral Initiatives with European Commission membership or contribution
Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
Since infectious diseases do not respect borders and spread rapidly, GloPID-R aims to improve the collaboration of funders that is paramount to establishing a rapid and effective global research response. The goal is to establish a response within 48 hours of an outbreak.
Global Alliance for Chronic Diseases (GACD)
Develops and facilitates innovative research collaborations between low-middle-income and high-income countries in the fight against chronic diseases.
Human Frontier Science Programme organisation (HFSP)
A global intercontinental programme, which finances innovative and interdisciplinary basic research at the frontier of the life sciences.
International Cancer Genome Consortium (ICGC)
Accelerates research into the causes and the control of cancer by generating comprehensive catalogues of genomic abnormalities in cancer tumours.
International Initiative for Traumatic Brain Injury Research (InTBIR)
Addresses, since 2011, the overall problem of traumatic brain injury (TBI) by establishing best practices in treatment, through strengthened global cooperation and collaboration.
International Human Epigenome Consortium (IHEC)
Aims at understanding the role of the human epigenome as cause of diseases and in the maintenance of health by providing 1000 high-resolution reference epigenome maps to the research community.
International Human Microbiome Consortium (IHMC)
Aims at understanding the role of the human microbiome as cause of diseases and in the maintenance of health and how to use that knowledge to improve the ability to prevent and treat disease.
International Knockout Mouse Consortium (IKMC)
Aims at mutating one by one, all protein-coding and small RNA genes in the mouse, leading to a better understanding of gene functions in human diseases.
International Rare Diseases Research Consortium (IRDiRC)
Aims to deliver by the year 2020, 200 new therapies for rare diseases and means to diagnose most rare diseases.